Published in Eur Radiol on December 19, 2002
Manganese accumulation in the brain: MR imaging. Neuroradiology (2007) 0.91
Safety of MR liver specific contrast media. Eur Radiol (2004) 0.90
Initial clinical experience with oral manganese (CMC-001) for liver MR imaging. Eur Radiol (2006) 0.79
Description of focal liver lesions with Gd-EOB-DTPA enhanced MRI. Clujul Med (2015) 0.75
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. Radiology (1992) 1.53
Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology (1991) 1.11
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology (1996) 1.01
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). J Magn Reson Imaging (2000) 0.93
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol (2000) 0.91
MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol (1997) 0.90
Mn-DPDP enhanced MRI in experimental bile duct obstruction. J Comput Assist Tomogr (1993) 0.90
Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology (1996) 0.87
MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol (1997) 0.86
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol (2001) 0.77
MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Invest Radiol (1998) 0.76
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology (1992) 0.76
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr (2004) 1.35
Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr (2005) 1.18
Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07
How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07
'Living and dying well with end-stage liver disease': time for palliative care? Hepatology (2013) 1.06
Pyoderma gangrenosum: a challenging complication of bilateral mastopexy. Int Wound J (2004) 1.06
Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl (2011) 1.01
Graft positioning at liver transplantation in situs inversus. Liver Transpl (2006) 1.01
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest (2009) 0.91
Traumatic pancreatic duct injury in children: minimally invasive approach to management. J Pediatr Surg (2007) 0.89
Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio. Scand J Clin Lab Invest (2009) 0.85
Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese women. Scand J Clin Lab Invest (2010) 0.79
Effect of loss of regional fat assessed by DXA on insulin resistance and dyslipidaemia in obese men. Scand J Clin Lab Invest (2010) 0.77
Primary Budd-Chiari Syndrome in Children: King's College Hospital Experience. J Pediatr Gastroenterol Nutr (2017) 0.75
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial. Eur J Endocrinol (2005) 0.75
Liver transplantation with caval thrombectomy and cavoatrial shunt in acute Budd-Chiari syndrome. Liver Transpl (2007) 0.75